Toes RE - Search Results

1

Cleavage of FLICE (caspase-8) by granzyme B during cytotoxic T lymphocyte-induced apoptosis.

Medema JP, Toes RE, Scaffidi C, Zheng TS, Flavell RA, Melief CJ, Peter ME, Offringa R, Krammer PH. Medema JP, et al. Among authors: toes re. Eur J Immunol. 1997 Dec;27(12):3492-8. doi: 10.1002/eji.1830271250. Eur J Immunol. 1997. PMID: 9464839

2

CD40-CD40Ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunity.

Toes RE, Schoenberger SP, van der Voort EI, Offringa R, Melief CJ. Toes RE, et al. Semin Immunol. 1998 Dec;10(6):443-8. doi: 10.1006/smim.1998.0147. Semin Immunol. 1998. PMID: 9826577 Review.

3

Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells.

Medema JP, Schuurhuis DH, Rea D, van Tongeren J, de Jong J, Bres SA, Laban S, Toes RE, Toebes M, Schumacher TN, Bladergroen BA, Ossendorp F, Kummer JA, Melief CJ, Offringa R. Medema JP, et al. Among authors: toes re. J Exp Med. 2001 Sep 3;194(5):657-67. doi: 10.1084/jem.194.5.657. J Exp Med. 2001. PMID: 11535633 Free PMC article.

4

Activation or frustration of anti-tumor responses by T-cell-based immune modulation.

Toes RE, Schoenberger SP, van der Voort EI, Kast WM, Hoeben RC, Melief CJ, Offringa R. Toes RE, et al. Semin Immunol. 1997 Oct;9(5):323-7. doi: 10.1006/smim.1997.0088. Semin Immunol. 1997. PMID: 9327527 Review.

5

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. Schoenberger SP, et al. Among authors: toes re. Nature. 1998 Jun 4;393(6684):480-3. doi: 10.1038/31002. Nature. 1998. PMID: 9624005

6

Cytotoxic T lymphocyte priming versus cytotoxic T lymphocyte tolerance induction: a delicate balancing act involving dendritic cells.

Melief CJ, Schoenberger S, Toes R, Offringa R. Melief CJ, et al. Haematologica. 1999 Jun;84 Suppl EHA-4:26-7. Haematologica. 1999. PMID: 10907460 Review. No abstract available.

7

Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumors.

Toes RE, Blom RJ, Offringa R, Kast WM, Melief CJ. Toes RE, et al. J Immunol. 1996 May 15;156(10):3911-8. J Immunol. 1996. PMID: 8621930

8

Efficient direct priming of tumor-specific cytotoxic T lymphocyte in vivo by an engineered APC.

Schoenberger SP, Jonges LE, Mooijaart RJ, Hartgers F, Toes RE, Kast WM, Melief CJ, Offringa R. Schoenberger SP, et al. Among authors: toes re. Cancer Res. 1998 Jul 15;58(14):3094-100. Cancer Res. 1998. PMID: 9679976

9

Cross-priming of CTL responses in vivo does not require antigenic peptides in the endoplasmic reticulum of immunizing cells.

Schoenberger SP, van der Voort EI, Krietemeijer GM, Offringa R, Melief CJ, Toes RE. Schoenberger SP, et al. Among authors: toes re. J Immunol. 1998 Oct 15;161(8):3808-12. J Immunol. 1998. PMID: 9780143

10

Strategies for immunotherapy of cancer.

Melief CJ, Toes RE, Medema JP, van der Burg SH, Ossendorp F, Offringa R. Melief CJ, et al. Among authors: toes re. Adv Immunol. 2000;75:235-82. doi: 10.1016/s0065-2776(00)75006-1. Adv Immunol. 2000. PMID: 10879286 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

460 results

Search Page

Filters